XML 88 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Financial Instruments (Tables)
12 Months Ended
Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Notional Amounts of Derivative Instruments

The table below presents the total volume or notional amounts of the Company’s derivative instruments as of September 30, 2019. Notional values are in U.S. dollars and are translated and calculated based on forward rates as of September 30, 2019 for forward contracts, and based on spot rates as of September 30, 2019 for options.

 

     Notional Value*  

Foreign exchange contracts

   $ 1,103,169  

 

(*)

Gross notional amounts do not quantify risk or represent assets or liabilities of the Company but are used in the calculation of settlements under the contracts.

Fair Value of Open Foreign Currency Exchange Contracts

The fair value of the open foreign exchange contracts recorded as an asset or a liability by the Company on its consolidated balance sheets as of September 30, 2019 and September 30, 2018, is as follows:

 

     As of September 30,  
     2019      2018  

Derivatives designated as hedging instruments

     

Prepaid expenses and other current assets

   $ 9,344      $ 221  

Other noncurrent assets

     585        25  

Accrued expenses and other current liabilities

     (2,977      (17,681

Other noncurrent liabilities

     (2,072      (10,030
  

 

 

    

 

 

 
     4,880        (27,465

Derivatives not designated as hedging instruments

     

Prepaid expenses and other current assets

     5,086        2,758  

Accrued expenses and other current liabilities

     (2,076      (3,135
  

 

 

    

 

 

 
     3,010        (377
  

 

 

    

 

 

 

Net fair value

   $ 7,890      $ (27,842
  

 

 

    

 

 

 

Effect of Cash Flow Hedging Instruments

The effect of the Company’s cash flow hedging instruments in the consolidated statements of income for the fiscal years ended September 30, 2019, 2018 and 2017, respectively, which partially offsets the foreign currency impact from the underlying exposures, is summarized as follows:

 

     (Losses) Gains Reclassified from
Other Comprehensive Income (Loss)
(Effective Portion)
Year Ended September 30,
 
     2019      2018      2017  

Line item in consolidated statements of income:

        

Revenue

   $ 19      $ (1,129    $ (1,021

Cost of revenue

     (8,627      15,877        21,783  

Research and development

     (2,059      3,127        4,282  

Selling, general and administrative

     (2,309      3,462        3,305  
  

 

 

    

 

 

    

 

 

 

Total

   $ (12,976    $ 21,337      $ 28,349  
  

 

 

    

 

 

    

 

 

 

Changes in Net Unrealized (Losses) Gains on Cash Flow Hedges

The activity related to the changes in net unrealized gains (losses) on cash flow hedges recorded in accumulated other comprehensive (loss) income, net of tax, is as follows:

 

     Year Ended September 30,  
     2019      2018      2017  

Net unrealized (loss) gain on cash flow hedges, net of tax, beginning of period

   $ (26,608    $ 24,508      $ 12,514  

Changes in fair value of cash flow hedges, net of tax

     19,228        (31,908      36,765  

Reclassification of loss (gain) into earnings, net of tax

     11,325        (19,208      (24,771
  

 

 

    

 

 

    

 

 

 

Net unrealized gain (loss) on cash flow hedges, net of tax, end of period

   $ 3,945      $ (26,608    $ 24,508  
  

 

 

    

 

 

    

 

 

 

 

Effect of Non-Designated as Hedging Instruments

The effect of the Company’s derivative instruments not designated as hedging instruments in the consolidated statements of income for the fiscal years ended September 30, 2019, 2018 and 2017, respectively, which partially offsets the foreign currency impact from the underlying exposure, is summarized as follows:

 

     Gains (Losses)
Recognized in Income
Year Ended September 30,
 
     2019      2018      2017  

Line item in statements of income:

        

Cost of revenue

   $ 401      $ (4,577    $ 4,639  

Research and development

     14        (736      957  

Selling, general and administrative

     294        (950      1,723  

Interest and other income (expense), net

     5,845        7,038        (10,514

Income taxes

     (528      1,581        (1,653
  

 

 

    

 

 

    

 

 

 

Total

   $ 6,026      $ 2,356      $ (4,848